Claudia Malacarne
Overview
Explore the profile of Claudia Malacarne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malacarne C, Giagnorio E, Chirizzi C, Cattaneo M, Saraceno F, Cavalcante P, et al.
Biomed Pharmacother
. 2024 Mar;
173:116380.
PMID: 38447450
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons. Considerable evidence indicates that early skeletal muscle atrophy plays a crucial role in the disease pathogenesis, leading to...
2.
Giagnorio E, Malacarne C, Cavalcante P, Scandiffio L, Cattaneo M, Pensato V, et al.
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36902041
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive, irreversible loss of upper and lower motor neurons (UMNs, LMNs). MN axonal dysfunctions are emerging as relevant pathogenic events since the...
3.
Bonanno S, Cavalcante P, Salvi E, Giagnorio E, Malacarne C, Cattaneo M, et al.
Front Cell Neurosci
. 2022 Aug;
16:982760.
PMID: 36035258
Background And Objectives: Multisystem involvement in spinal muscular atrophy (SMA) is gaining prominence since different therapeutic options are emerging, making the way for new SMA phenotypes and consequent challenges in...
4.
Rey F, Marcuzzo S, Bonanno S, Bordoni M, Giallongo T, Malacarne C, et al.
Biomedicines
. 2021 Aug;
9(7).
PMID: 34356873
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease caused in 10% of cases by inherited mutations considered "familial". An ever-increasing amount of evidence is showing a fundamental role for...
5.
Giagnorio E, Malacarne C, Mantegazza R, Bonanno S, Marcuzzo S
J Cell Sci
. 2021 Jun;
134(12).
PMID: 34137441
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of both upper and lower motor neurons (MNs). The main clinical features of ALS are motor function impairment,...
6.
Malacarne C, Galbiati M, Giagnorio E, Cavalcante P, Salerno F, Andreetta F, et al.
Int J Mol Sci
. 2021 Jun;
22(11).
PMID: 34073630
Motor neuron diseases (MNDs) are neurodegenerative disorders characterized by upper and/or lower MN loss. MNDs include amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and spinal and bulbar muscular atrophy...
7.
Bonanno S, Marcuzzo S, Malacarne C, Giagnorio E, Masson R, Zanin R, et al.
Biomedicines
. 2020 Jan;
8(2).
PMID: 31991852
Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations in survival motor neuron (SMN) 1 gene, resulting in a truncated SMN protein responsible for degeneration of brain...
8.
Marcuzzo S, Isaia D, Bonanno S, Malacarne C, Cavalcante P, Zacheo A, et al.
Cells
. 2019 Mar;
8(3).
PMID: 30909571
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons. In ALS mice, neurodegeneration is associated with the proliferative restorative attempts of ependymal stem progenitor cells (epSPCs) that...